Skip to content
    SPRO stock page

    Spero Therapeutics, Inc.

    SPRO · earnings call history

    1 call analysed
    1. Jun 2026Q2 FY26Aug 12, 2026

      Spero Therapeutics Q2 FY26 — FDA Approval, Pipeline Repositioning, and Strategic Financing

      Read the brief

    Browse all US companies on the earnings-call register.